Jun 14 |
A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference
|
Jun 14 |
SNGX: Valuation Change Based on Reverse Split…
|
Jun 7 |
Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
Jun 5 |
Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial
|
May 31 |
Soligenix to effect 1-for-16 reverse stock split
|
May 31 |
Soligenix Announces Reverse Stock Split
|
May 29 |
Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting
|
May 24 |
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
|
May 16 |
Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice
|
May 14 |
SNGX: Second Confirmatory Phase 3 Trial of HyBryte™ in CTCL to Initiate Before End of 2024…
|